Quinazolines -1,3-benzodiazines are biological active compounds, which are used in the phamaceutical industry, in agriculture and in the medicine. As documented in the literature, many derivatives demonstrated anticancer activity and they act as multitarget agents. 3-(5-Nitro-2-thienyl)-9-chloro-5-morpholin-4-yl[1,2,4]triazolo[4,3-c] quinazoline (NTCHMTQ) -a new synthetically prepared quinazoline derivative was the most effective derivative in our primary cytotoxic screening. In this study, we evaluated cytotoxic/antiproliferative activity of NTCHMTQ using human tumor cell line HeLa. Possible interaction of 3-(5-nitro-2-thienyl)-9-chloro-5-morpholin-4-yl[1,2,4]triazolo[4,3-c] quinazoline with calf thymus DNA was tested by the DNA -modified screen -printed electrode. Quinazoline derivative acted cytotoxically on tumor cell line HeLa. The IC 100 value was 10 µg/ml. The IC 50 values was found to be less than 4 µg/ml, a limit put forward by the National Cancer Institute (NCI) for classiffication of he compound as a potential anticancer drug. Quinazoline at micromolar concentrations induced morphological changes and necrosis of HeLa cells. Using the DNA based electrochemical biosensor, we have not found damage to DNA under in vitro conditions at an incubation of the biosensor in mixture with quinazoline.
INTRODUCTION
Quinazoline derivatives are used in the pharmaceutical industry, in medicine and in agriculture because of their antimicrobial, anti-inflammatory, diuretic, anticonvulsant, antiallergic, antihypertensive, antiparkinsonian effects and other properties [1] [2] [3] [4] . As documented in the literature, many derivatives act as anticancer active compounds and they act as multitarget agents. They are antifolate thymidylate synthase inhibitors; epidermal growth factor receptor tyrosine kinase inhibitors; inhibitors of enzymes dihydrofolate reductase and tyrosine kinase, aldose reductase and cyclic GMP phosphodiesterase. Some quinazolines interact with cytoskeleton, they induce apoptosis and affect DNA topoisomerase [5] [6] [7] [8] [9] . 3-(5-Nitro-2-thienyl)-9-chloro-5-morpholin-4-yl- [1, 2, 4] tria zolo [4,3-c] quinazoline (NTCHMTQ) is new synthe ti cally prepared derivative, which in our previous study showed cytotoxic effects on cancer cell line B16. Quinazoline at micromolar concentrations induced morphological changes and necrosis of B16 cells, at nanomolar concentrations it demonstrated changes of F-actin cytoskeleton. It did not cause changes in cell cycle, did not induce apoptotic cell death in B16 cells, did not have mutagenic effect.
The interactions of some anticancer agents with DNA have been investigated by a variety of techniques and there is a growing interest in the electrochemical methods for the determination of anticancer agents.
In this study, we investigated the cytotoxic effect of 3-(5-nitro-2-thienyl)-9-chloro-5-morpholin-4-yl- [1, 2, 4] triazolo [4,3-c] quinazoline on further cancer cell line HeLa and the electrochemical interaction of quinazoline with dsDNA at carbon paste electrode.
MATERIAL AND METHODS
We used the human tumor cell line HeLa obtained from the American Type Culture Collection (Rockville, MD, USA) which was adherently grown and propagated in supplemented minimal Eagle medium (Biocom Bratislava, Slovak Republic). Quinazoline prepared by Špirková et al. 10, 11 was dissolved in dimethyl sulfoxide (DMSO). All other chemicals were obtained from Sigma Chemicals (St Louis, MD).
Antiproliferative activity in vitro was measured by the cell growth inhibition assay. After 24 h of incubation, the HeLa cells (the starting inoculum of 3 × 10 4 cells/ml) were treated with quinazoline (concentrations of 100, 75, 50, 10, 1, 0.1 µg/ml). Control cells were treated with DMSO, its final concentration never exceeded 1%. After 24, 48 and 72 h of quinazoline treatment, HeLa cells were harvested in triplicate, first washed with PBS, then harvested by 0.25 % trypsin, and latter resuspended. Cell growth and viability were assessed by direct counting of 0.4% trypan blue dye-excluding cells.
DNA-modified screen-printed carbon electrode was applied to the study of interaction between quinazoline and DNA at the electrode surface 12 . A computerized voltammetric analyzer ECA pol. fitted with a screen-printed three-electrode assembly including a carbon working electrode (SPE, 25 mm 2 geometric surface area), a silver/silver chloride reference electrode (Ag/AgCl/SPE with potential of 0.284 V vs conventional Ag/AgCl/sat. KCl electrode) and a carbon counter electrode was used for voltammetric measurements. The working electrode without any electrochemical preconditioning was chemically modified ex situ by covering with 5 µl of the dsDNA stock solution and leaving the electrode to dry overnight.
Calf thymus dsDNA was obtained from Merck. Its stock solution (0.1 mg/ml) was prepared in 1 × 10 [1, 2, 4] triazolo [4,3-c] quinazoline on human cancer cell line HeLa had an acute cytolytic effect manifested by degeneration -lysis (necrosis) of certain parts of the HeLa cells. In the next time intervals the degeneration of cell population increased. The concentration of 10 mg/l induced a delayed cytotoxic effect. After 24 h of culturing 39.1% of the cell population proliferated but after 48 h and 72 h 100 % degeneration of cell population was found. The concentration 1.0 mg/l of NTCHMTQ induced a cytotoxicity that was time-dependent. The HeLa cells treated for 72 h with the lowest concentration (0.1 µg/ml) grew as well as the control cells. These changes in viable cell number were also observed when aliquots of the cultures were examined by light microscopy. The cytolytic effect of NTCHMTQ observed by light microscopy at concentrations 100, 75, 50 µg/ml for HeLa cells during 72 h of culturing is illustrated in Fig. 2 . The control cells (Fig. 2a) Table 1) . Calf thymus DNA on biosensor was exposed to different concentrations (100, 50, 10, 1, 0.1 µg/ml) of NTCHMTQ. Typical DP voltammograms of the [Co(phen) 3 ] 3+ complex obtained at the DNA/SPE without and with quinazoline are shown in Fig. 3 .
Cytotoxicity and detection of damage to DNA by 3-(5-nitro-2-thienyl)-9-chloro-5-morpholin-4-yl
The treatment of the sensor in solution of quinazoline did not lead to a change in the signal. We can see (Fig. 3, Table 1 ) that NTCHMTQ did not cause change in calf thymus dsDNA. The little damage of dsDNA (only 9.3 %) was discovered only at concentration of 100 mg/l. A potential shift of the guest molecule is usually taken as a confirmation of its binding mode.
Based on results obtained here we can conclude that 3-(5-nitro-2-tienyl)-9-chloro-5-morpholine-4-yl- 3+ complex was used. Concentrations of tested quinazoline were 100, 50, 10, 1, 0.1 µg/ml.
The DNA/SPE sensor was pre-treated by immersing to 5 mmol/l phosphate buffer solution (PBS) pH 7.0 under stirring for 5 min, and then rinsed with water. The [Co(phen) 3 ] 3+ marker was accumulated from 5 ml of its 5×10 -7 mol/l solution in 5 mmol/l PBS under stirring for 120 s at an open circuit. The differential pulse voltammogram (DPV) was recorded immediately from + 0.300 to -0.500 V at the pulse amplitude of 100 mV, 2 mV scan step and the scan rate of 10 mV/s. The marker DPV peak current (I o ) was obtained using the evaluation against a base-line by standard software and the correction substancing the mean marker peak current measured at the unmodified SPE under the same condirions. Then, the DNA/SPE sensor was regenerated by a removal of the electrostatically accumulated [Co(phen) 3 ] 3+ ions from the DNA layer at treating in the buffer medium of higher ionic strength (1×10 -1 mol/l PBS pH 7.0) under stirring during 60 s. To detect the damage to DNA, the same DNA sensor was incubated in a separate cell in the quinazoline mixture in 5 mmol/l PBS for 10 min under stirring and then rinsed with water. The marker peak current (I) was obtained again in duplicate using the DPV measurement/biosensor regeneration scheme and the normalized (relative) signal I/I 0 was calculated. Figure 1 represents the growth curves of HeLa cells treated for up to 72 h with NTCHMTQ at concentrations ranging from 100 µg/ml to 0.1 µg/ml. After 24 h, the three highest concentrations tested (100, 75 and 50 µg/ml) 
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